Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Neos Therapeutics, Inc. (NEOS)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/16/2021 |
SC 13G/A
| SPHERA FUNDS MANAGEMENT LTD. reports a 0% stake in Neos Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 10% stake in Neos Therapeutics, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/13/2020 |
SC 13G/A
| Broadfin Capital, LLC reports a 0% stake in Neos Therapeutics, Inc. |
| 02/13/2020 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 9.8% stake in Neos Therapeutics, Inc. |
| 02/13/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/11/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 07/10/2019 |
SC 13G/A
| BlackRock Inc. reports a 1.1% stake in NEOS THERAPEUTICS, INC |
| 02/13/2019 |
SC 13G/A
| Stonepine Capital Management, LLC reports a 8.5% stake in Neos Therapeutics, Inc. |
| 01/28/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/07/2018 |
SC 13G/A
| BlackRock Inc. reports a 4.5% stake in NEOS THERAPEUTICS, INC |
| 11/30/2018 |
SC 13G/A
| Flynn James E reports a 5% stake in Neos Therapeutics, Inc. |
| 02/14/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2018 |
SC 13G/A
| Presidio Partners 2007 GP, LLC reports a 1.7% stake in Neos Therapeutics, Inc. |
| 02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/07/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/06/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/31/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 04/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 03/10/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/13/2017 |
SC 13G/A
| Presidio Partners 2007 GP, LLC reports a 9.4% stake in Neos Therapeutics, Inc. |
| 02/09/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/08/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 02/02/2017 |
SC 13G/A
| Iannelli Ralph reports a 7.6% stake in Neos Therapeutics, Inc. |
| 01/10/2017 |
SC 13G/A
| Delaware Street Capital Master Fund, L.P. reports a 4.3% stake in Neos Therapeutics, Inc. |
|
|